Abstract
Lipopolysaccharide (LPS) is known to elicit a robust immune response. This study aimed to investigate the impact of LPS on the transcriptome of human nasal epithelial cells (HNEpC). HNEpC were cultured and stimulated with LPS (1 μg/mL) or an equivalent amount of normal culture medium. Subsequently, total RNA was extracted, purified, and sequenced using next-generation RNA sequencing technology. Differentially expressed genes (DEGs) were identified and subjected to functional enrichment analysis. A protein–protein interaction (PPI) network of DEGs was constructed, followed by Ingenuity Pathway Analysis (IPA) to identify molecular pathways influenced by LPS exposure on HNEpC. Validation of key genes was performed using quantitative real-time PCR (qRT-PCR). A total of 97 DEGs, comprising 48 up-regulated genes and 49 down-regulated genes, were identified. Results from functional enrichment analysis, PPI, and IPA indicated that DEGs were predominantly enriched in chemokine-related signaling pathways. Subsequent qRT-PCR validation demonstrated significant upregulation of key genes in these pathways in LPS-treated HNEpC compared to control cells. In conclusion, LPS intervention profoundly altered the transcriptome of HNEpC, potentially exacerbating inflammatory responses through the activation of chemokine-related signaling pathways.
Similar content being viewed by others
Introduction
Lipopolysaccharide (LPS), also known as endotoxin, is a complex molecule composed of lipids and polysaccharides (glycolipids), constituting a major component of the outer membrane in certain bacteria, particularly gram-negative bacteria1,2,3. LPS exhibits intricate biological activities, serving as an immune enhancer that elicits a robust immune response during bacterial infections. It activates various immune cells, including T lymphocytes, B lymphocytes, and macrophages, while also promoting cytokine production, complement activation, and overall immune enhancement4,5,6.
Nasal epithelial cells, forming the outermost barrier of nasal mucosal tissue, are the primary targets of external pathogenic agents such as bacteria, viruses, and environmental pollutants. This epithelial barrier plays a crucial role in preventing the entry of harmful substances and microorganisms into the lower respiratory tracts, including the bronchi and lungs7,8. Numerous studies have demonstrated that external bacteria can invade nasal epithelial cells, compromising the epithelial barrier and triggering a cascade of inflammatory and immune responses9,10. LPS is commonly employed to mimic external pathogenic bacteria in research models studying the invasion of nasal epithelial cells11.
As described above, LPS plays a key role in the inflammatory response associated with respiratory diseases. Nasal epithelial cells serve as the primary target for external pathogenic bacteria. However, the precise involvement of LPS in provoking inflammatory responses in nasal epithelial cells, its impact on their transcriptome, and the specific underlying mechanisms remain uncertain. In light of these uncertainties, our aim was to investigate the influence of LPS on the transcriptome of human nasal epithelial cells (HNEpC) in vitro. Our investigation encompassed the identification of differentially expressed genes (DEGs), the execution of principal component analysis (PCA), and the undertaking of comprehensive functional analyses, which included gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA). Additionally, we conducted Protein–protein interaction (PPI) network analysis and employed Ingenuity Pathways Analysis (IPA). The overarching objective was to elucidate the specific mechanisms governing the inflammatory responses induced by LPS in HNEpC.
Materials and methods
HNEpC culture and LPS stimulation
HNEpC cells (PromoCell, C-12620, Heidelberg, Germany) were cultured in airway epithelial cell basal medium (PromoCell, C-21060) supplemented with the growth medium kit (PromoCell, C-21160) in a 5% CO2 incubator at 37 °C. Subsequently, HNEpC cells were cultured and stimulated with LPS (1 μg/mL, L2880, Sigma-Aldrich, St. Louis, MO, USA) or an equal volume of normal culture medium for 6 h. All concentrations of stimulators mentioned herein represent the final concentrations.
Cell viability tests
HNEpC cells were diluted to 1 × 105/mL with airway epithelial cell culture medium and seeded in sterile 96-well culture plates in a 5% CO2 incubator at 37 °C for 24 h. The LPS stock solution was diluted to various concentrations (0.125, 0.25, 0.5, 1, 2, and 4 μg/mL) with airway epithelial cell culture medium. Control wells received an equal volume of culture medium, and blank wells had no cells. The MTT Assay Kit was employed to determine the number of viable cells using the formula: Cell viability = (LPS-treated well − blank well)/(control well − blank well) × 100%. Additional details are available in the Supporting Information of this article.
Transcriptome sequencing of HNEpC stimulated by LPS
Transcriptome sequencing of HNEpC cells stimulated by LPS was conducted for further bioinformatics analysis. Initially, HNEpC cells were cultured in a 6-well plate at 37 °C with 5% CO2. Before stimulation, the LPS stock solution was diluted to 1 μg/mL with normal culture medium. Three experimental groups of HNEpC cells were exposed to 2 mL of 1 μg/mL LPS suspension for 6 h, and three control groups were treated with the same amount of normal culture medium for the same duration. Subsequently, total RNA of HNEpC cells was extracted, sent to Shanghai Bohao Biotechnology Co., Ltd. (Shanghai, China), and subjected to RNA extraction, purification, RNA-seq, data processing, and bioinformatics analysis. The statistical summary of the HNEpC transcriptome for sequencing is presented in Table S1, and raw expression data were deposited in the Gene Expression Omnibus (GEO) database (GSE241554).
PCA, DEGs identification, GO, KEGG and GSEA analyses in our transcriptome data
PCA, DEGs identification, GO, KEGG, and GSEA analyses on our transcriptome data were performed using the "ggplot2," "edgeR," and "clusterProfiler" R packages. The "edgeR" R package was applied to assess the expression levels between LPS-treated groups and control groups, with the criteria for DEG selection being adjusted p value (q value) < 0.05 and |Log2 fold change (Log2FC)|> 1. GO, KEGG, and GSEA analyses utilized the "clusterProfiler" R package, considering pathways with a q value < 0.05 as significantly enriched. The gene list was pre-ranked by fold changes for GSEA, using canonical pathways gene sets from the KEGG pathway database (mSigDB C2 category) downloaded from the "Molecular Signatures Database v2023.1." Normalized enrichment score (NES) was used to evaluate enrichment degree, with a significance threshold of p < 0.05, false discovery rate (FDR) < 0.25, and |NES|> 1 deemed statistically significant.
PPI network analysis and construction
PPI network analysis was conducted using the Search Tool for the Retrieval of Interacting Genes (STRING) (version 11.5, https://string-db.org) with a threshold of combined score > 0.4, subsequently visualized by Cytoscape (version: 3.9.1, https://cytoscape.org/)12. The closeness parameter of each node was calculated using the "cytoHubba" plugin of Cytoscape and used to rank all nodes.
IPA analysis
The results of DEGs containing gene identifiers, corresponding log2 fold changes, and FDR values were uploaded into the IPA software (version 1.0, https://digitalinsights.qiagen.com/; Qiagen Bioinformatics, Redwood City, CA, USA) and analyzed with the "core analysis" function. Enrichment pathways of DEGs were generated based on the Ingenuity Pathway Knowledge Data Base. The results of enriched pathways were ranked by –log10 (p-value).
Quantitative real-time PCR (qRT-PCR) verification
To verify the results of RNA sequencing, key DEGs including CXCL1, CXCL8, CXCL10, CCL20, RELB, LCN2, BIRC3, NFKBIZ, IRAK2, PI3, SAA1, CSF3, and CSF1 were chosen for qRT-PCR (Table S5) assay on the RNA of HNEpC. qRT-PCR was performed using the SYBR Green method with specific primers (Table S6). Additional information is available in the Supporting Information of this article.
In addition, in order to further verify the results of transcriptome sequencing and bioinformatics analysis, we isolated primary human nasal epithelial cells (pHNEpC) from inferior turbinate tissues obtained from six patients (three males and three females) of median age 38 years (range 19 to 58 years) undergoing septoplasty for a deviated septum. These pHNEpC were seeded in 6-well culture plates coated with collagen (5005, PureCol® Type I Collagen Solution, Advanced BioMatrix) and cultured in serum-free bronchial epithelial cell growth medium (BEGM, Lonza, Walkersville, Md) in an incubator at 37 °C and 5% CO2. Then, pHNEpC cells were cultured and stimulated with LPS (1 μg/mL) or an equal volume of normal culture medium for 6 h. Following stimulation, total RNA of these cells was extracted for qRT-PCR assay.
This study was approved by the Ethical Committee of Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and all subjects provided informed consent. All methods were carried out in accordance with relevant guidelines and regulations.
Statistical analysis
The data were expressed as means ± standard deviation (SD), unless noted otherwise. Bioinformatics analyses were performed using R language (version 4.3.2, https://cloud.r-project.org/; R Core Team) in the RStudio environment (version 2023.09.1 + 494, https://posit.co/; RStudio Team). Statistical analysis was performed using SPSS (version 26.0, https://www.ibm.com/spss; IBM) and GraphPad Prism (version 9.0, https://www.graphpad.com/; GraphPad Software). Mann Whitney U test was used to compare the differences between the control group and LPS treated group, and p < 0.05 was deemed statistically significant.
Results
LPS intervention induces damage to HNEpC
The MTT cell survival test results illustrate a significant decrease in cell viability upon stimulation with LPS at concentrations of 2 μg/mL (p = 0.043) and 4 μg/mL (p = 0.009, Fig. 1A).
LPS alters the transcriptome of HNEpC
The PCA plot reveals a clear differentiation between the LPS stimulation group (located on the left) and the control group (distributed on the right), highlighting the pronounced disparity between the two groups (Fig. 1B). To identify DEGs following LPS intervention, the "edgeR" R package was employed with screening criteria set at | log2fold change |> 1.0 and q value < 0.05. A total of 97 genes were identified as DEGs, comprising 48 up-regulated genes and 49 down-regulated genes (Fig. 1C–E). The clustered heatmap of all DEGs is presented in Fig. 1E, and the complete lists of DEGs are available in Table S2. The top 50 significant DEGs, exhibiting the highest log2 fold changes, are depicted in Fig. 1F.
Functional enrichment analyses of DEGs
Subsequently, we conducted GO, KEGG and GSEA pathways analyses to elucidate the biological functions of DEGs. We identified 59 significantly enriched GO terms (q < 0.05), encompassing 50 terms in biological process (BP), 1 term in cellular component (CC), and 8 terms in molecular function (MF) (Table S3). A bubble plot displaying the top 50 GO terms with the highest rich factors is presented in Fig. 2A. Notably, chemokine-related signaling pathways, including CXCR chemokine receptor binding, cellular response to interleukin-17 (IL-17), and response to chemokine, were significantly enriched GO terms. In order to further visualize the relationship between enriched GO term or KEGG pathways and related genes, we used chord and circle diagrams for visualization. In a chord diagram, each arc in the diagram represents a GO term or KEGG pathway, and the chords connecting the arcs indicate the genes that are shared between those terms. In a circle diagram, each circle in the diagram represents a GO term or KEGG pathway. The size of the circle is proportional to the significance or enrichment level of the term or pathway, and the size of the circle is directly proportional to the number of genes associated with the GO term or KEGG pathway. Highly enriched terms or pathways have larger circles, while less enriched terms have smaller circles. Notably, the relationships between enriched GO terms and related genes are clearly and intuitively displayed (Fig. 2B,C). Enriched GO terms such as granulocyte chemotaxis, response to chemokine, cellular response to chemokine, granulocyte migration, and neutrophil chemotaxis are represented by arcs in the diagram. Key genes associated with these GO terms, including CSF3, CXCL1, CXCL8, CCL20, SAA1, CXCL10, et al., are indicated by the arcs connecting the GO term chords, or the gene circles connecting the GO term circles (Fig. 2B,C).
Next, based on KEGG database13,14,15, KEGG pathway enrichment analysis of DEGs identified 15 significantly enriched pathways (q < 0.05) (Table S4). The top 20 KEGG pathways with the highest GeneRatio were displayed in a bubble plot (Fig. 3A), revealing the significant enrichment of chemokine-related signaling pathways, including IL-17 signaling pathway and TNF signaling pathway. Notably, the relationships between enriched KEGG pathways and related genes are clearly and intuitively displayed (Fig. 3B,C). Enriched KEGG pathways such as IL-17 signaling pathway, TNF signaling pathway, NF-kappa B signaling pathway, et al. are represented by arcs in the diagram. Key genes associated with these KEGG pathways, including CSF3, CXCL1, CXCL8, CCL20, CXCL10, et al., are indicated by the arcs connecting the KEGG pathways chords, or the gene circles connecting the KEGG pathways circles (Fig. 3B,C).
The GO and KEGG enrichment analyses consistently demonstrated significant enrichment of chemokine-related signaling pathways, including CXCR chemokine receptor binding, cellular response to IL-17, chemokine activity, granulocyte chemotaxis, and cell chemotaxis pathways (Fig. 4A,B). Additionally, genes involved in chemokine signaling pathway including CXCL10, CXCL8, CXCL1 and CCL20 also participated in several other pathways including IL-17 signaling pathway, TNF signaling pathway and Cytokine-cytokine receptor interaction (Fig. 4C). Notably, volcano plot analysis highlighted key chemokines, including CXCL8, CXCL1, and CCL20, as the most significantly altered genes in LPS-treated HNEpC (Fig. 4D).
To further elucidate critical pathways enriched in HNEpC treated with LPS, GSEA was conducted utilizing the KEGG database. The GSEA barplot and enrichment plot (Fig. 5A,B) revealed that, in line with the previously obtained GO and KEGG results, the chemokine signaling pathway (p-value = 0.014749, p.adjust = 0.1278), IL-17 signaling pathway (p-value = 0.002762, p.adjust = 0.0594), and TNF signaling pathway (p-value = 0.005848, p.adjust = 0.0752) exhibited significant enrichment in HNEpC treated with LPS.
PPI network of DEGs
For the PPI network of DEGs, a network comprising 67 nodes and 67 edges was established by uploading potential targets (DEGs) from HNEpC treated with LPS to the STRING database (https://www.string-db.org/). After excluding genes with low connectivity, the resulting PPI network featured 67 nodes and 67 edges (Fig. 5C). The cytoHubba plugin identified the top 22 hub genes based on the closeness parameter, including CXCL8, CCL20, CXCL1, RELB, LCN2, CXCL10, NFKBIZ, PI3, CSF3, and IRAK2, among others. Notably, genes associated with chemokine-related signaling pathways, such as CXCL8, CCL20, CXCL1, RELB, LCN2, CXCL10, NFKBIZ, PI3, CSF3, and IRAK2, ranked among the top 10 hub genes with the highest degree values in the innermost circle (Fig. 5D).
IPA of DEGs
The IPA of DEGs involved a functional enrichment analysis using the "core analysis" function. Pathways with a –log10 (p-value) > 2.5 were visualized in Fig. 6A, along with corresponding z-scores indicating positive or negative correlation with the intervention. The IPA analysis (Fig. 6A,B) revealed a significant upregulation of IL-17A signaling-related pathways, primarily encompassing CCL20, CXCL1, CXCL0, and CXCL8 in LPS-treated HNEpC. Additionally, pathways related to neurotransmitters, nervous system signaling, pathogen-influenced signaling, cellular immune response, disease-specific pathways, and cytokine signaling pathways exhibited the highest z-scores and the largest number of genes (Fig. 6C).
Furthermore, upstream regulators and target molecules analyses (Fig. 7A,B) identified CG, IL17A, IL1A, IL1B, IL1RAP, IL1RL2, IL36A, IL36G, JUN, NFkB (complex), NPM1, STAT3, and TNF as upstream regulators, while BIRC3, CCL20, CSF1, CSF3, CXCL1, CXCL10, CXCL8, NFKBIZ, and SAA1 were identified as key target molecules in the LPS-treated and control HNEpC dataset. This suggests that key genes in chemokine-related signaling pathways are crucial target molecules in our dataset, consistent with the results of the GO and KEGG enrichment analyses.
Moreover, the graphical summary of the LPS-treated and control HNEpC dataset (Fig. 7C) illustrated that LPS induces stimulation of leukocytes, immune response of cells, antimicrobial response, neuroinflammation signaling pathway, IFNG immune response of phagocytes, immune response of neutrophils, and infection of mammalia.
Gene expressions validation by qRT‐PCR analysis
To validate the gene expressions, qRT-PCR analysis was performed. The results confirmed a significant increase in the relative mRNA expression levels of CXCL1, CXCL8, CXCL10, CCL20, RELB, LCN2, BIRC3, NFKBIZ, IRAK2, PI3, SAA1, CSF3, and CSF1 in HNEpC or pHNEpC treated with LPS compared to the control group (Fig. 8A,B). Therefore, it can be concluded that chemokine-related signaling pathways may play a pivotal role in the pathogenesis of LPS-induced inflammatory responses in nasal epithelial cells.
Discussion
HNEpC, situated on the nasal cavity's inner surface, function as a primary defense against inhaled pathogens, particles, and irritants7,16. Interaction between LPS and HNEpC in nasal mucosal tissues triggers immune responses and inflammatory reactions. This interaction leads to the production and release of pro-inflammatory cytokines, chemokines, and other immune mediators that signal immune cell recruitment, particularly neutrophils and macrophages, to the nasal passages. These immune cells play crucial roles in combatting infections by engulfing pathogens and contributing to the inflammatory responses17.
In this study, RNA sequencing and bioinformatics analyses revealed a total of 97 DEGs, with 48 up-regulated and 49 down-regulated genes between LPS-treated HNEpC and control groups (Fig. 1 and Table S2). This indicates that LPS induces transcriptome alterations in HNEpC, aligning with previous findings in porcine peripheral blood mononuclear cells18 and mouse macrophages19.
Subsequent GO, KEGG, and GSEA analyses were employed to delineate the biological functions of DEGs. A total of 59 significantly enriched GO terms (q < 0.05) were identified (Table S3). The top 50 GO terms, with the highest enrichment factors, were depicted in a bubble plot (Fig. 2A). Notably, chemokine-related signaling pathways, such as CXCR chemokine receptor binding, cellular response to IL-17, granulocyte chemotaxis, neutrophil migration, and granulocyte migration, were among the significantly enriched GO terms. KEGG analysis results (Table S4, Figs. 3, and 4B) further confirmed significant enrichment in chemokine-related signaling pathways, including the IL-17 signaling pathway, TNF signaling pathway, and chemokine signaling pathway. Then, we utilized chord diagrams and circle diagrams to visually and intuitively represent the relationships between enriched GO terms or KEGG pathways and the genes associated with them, and further confirmed that chemokine-related GO terms or KEGG pathways were enriched and the interconnectedness between these processes (represented by GO terms or KEGG pathways) and the genes involved were close (Figs. 2B,C, 3B,C). Genes participating in the chemokine signaling pathway, such as CXCL10, CXCL8, CXCL1, and CCL20, were also involved in related pathways, including IL-17 signaling, TNF signaling, and cytokine-cytokine receptor interaction (Fig. 4C). Additionally, GSEA analysis reinforced the significant enrichment of chemokine signaling, IL-17 signaling, and TNF signaling pathways in LPS-treated HNEpC (Fig. 5A,B). Collectively, these results indicate the activation of chemokine-related signaling pathways in response to LPS stimulation in HNEpC, crucial for recruiting inflammatory cells to combat infections and induce inflammatory responses in nasal mucosal tissues17,20.
In our investigation, we employed GO, KEGG, and GSEA to elucidate the biological functions of DEGs. We identified a total of 59 significantly enriched GO terms (q < 0.05), with the top 50 terms and their respective enrichment factors displayed in a bubble plot (Fig. 2A) and detailed in Table S3. Notably, these enriched GO terms highlighted the involvement of chemokine-related signaling pathways, such as CXCR chemokine receptor binding, cellular response to IL-17, granulocyte chemotaxis, neutrophil migration, granulocyte migration, among others. Our KEGG analysis results (Table S4, Figs. 3, and 4B) further revealed the significant enrichment of chemokine-related signaling pathways, including the IL-17 signaling pathway, TNF signaling pathway, and chemokine signaling pathway. Intriguingly, several genes participating in the chemokine signaling pathway, such as CXCL10, CXCL8, CXCL1, and CCL20, were also implicated in other pathways, including IL-17 signaling, TNF signaling, and Cytokine-cytokine receptor interaction (Fig. 4C). These key chemokines, including CXCL8, CXCL1, and CCL20, were prominently positioned in the upper right quadrant of the volcano plot, signifying their significant alteration in HNEpC treated with LPS (Fig. 4D). Subsequent GSEA analysis validated the enrichment of chemokine signaling pathway, IL-17 signaling pathway, and TNF signaling pathway in LPS-treated HNEpC (Fig. 5A,B). In summary, our comprehensive analyses demonstrate the activation of chemokine-related signaling pathways in HNEpC following LPS stimulation. This activation is crucial for recruiting inflammatory cells, such as eosinophils, neutrophils, macrophages, T cells, and B cells, to combat infections, thereby inducing an inflammatory response in nasal mucosal tissues. This phenomenon may play a pivotal role in the pathogenesis of nasal inflammation17,20.
Subsequently, a PPI network analysis identified genes in chemokine-related signaling pathways, including CXCL8, CCL20, CXCL1, RELB, LCN2, CXCL10, NFKBIZ, PI3, CSF3, and IRAK2, among the top 10 hub genes with the highest degree values located in the innermost circle (Fig. 5D). Further investigation using IPA revealed a significant upregulation of IL-17A signaling-related pathways, primarily involving CCL20, CXCL1, CXCL0, and CXCL8, in LPS-treated HNEpC (Fig. 6A,B). Additionally, IPA upstream regulators and target molecules analyses (Fig. 7A,B) identified BIRC3, CCL20, CSF1, CSF3, CXCL1, CXCL10, CXCL8, NFKBIZ, and SAA1 as key target molecules in both LPS-treated and control HNEpC datasets. This finding is consistent with the earlier results of GO and KEGG enrichment analyses. The graphical summary of the LPS-treated and control HNEpC dataset (Fig. 7C) illustrated that LPS induces the stimulation of leukocytes, immune cell responses, antimicrobial reactions, neuroinflammation signaling, IFNG immune responses, neutrophil immune responses, and mammalian infections. These outcomes align with previous reports indicating that LPS triggers and activates immune responses in various leukocytes, including eosinophils21, neutrophils22, macrophages23, T cells24, B cells25, and mast cells26.
Finally, the results of qRT-PCR confirmed a significant elevation in the relative mRNA expression levels of key genes, including CXCL1, CXCL8, CXCL10, CCL20, RELB, LCN2, BIRC3, NFKBIZ, IRAK2, PI3, SAA1, CSF3, and CSF1, in LPS-treated HNEpC or pHNEpC compared to the control group (Fig. 8). This substantiates the activation of key genes in chemokine-related signaling pathways and underscores their crucial role in the pathogenesis of LPS-induced inflammatory responses in HNEpC. As depicted in Fig. 9, the transcriptome of HNEpC undergoes significant alterations following LPS intervention. Our bioinformatics analysis identified 97 DEGs, with chemokine-related signaling pathways, including the IL-17 signaling pathway, TNF signaling pathway, and chemokine signaling pathway, prominently activated in LPS-treated HNEpC. This activation suggests that LPS regulates the expression of key genes in these signaling pathways, further contributing to inflammatory responses in HNEpC.
As stated above, HNEpC act as the first line of defense against inhaled pathogens, such as LPS, inducing inflammatory responses upon contact in nasal mucosal tissues. This interaction leads to the increased production and release of chemokines and the activation of related signaling pathways, including the IL-17 signaling pathway, TNF signaling pathway, and chemokine signaling pathway. Consequently, immune cells, including eosinophils21, neutrophils22, macrophages23, T cells24, B cells25, and mast cells26 are recruited and migrate to the site of bacterial invasion. This orchestrated immune response aims to combat infections by inducing inflammatory immune responses and engulfing pathogens14.
Some limitations of our study need to be discussed. First, to obtain a stable baseline of mRNA expression for RNA sequencing and avoid heterogeneity which may confuse the effects of LPS stimulation, we chose a commercial cell line HNEpC cell (PromoCell) with greater stability, less genetic variation and heterogeneity, and higher repeatability than primary epithelial cells directly isolated from human or animal tissues for cell culture and stimulation experiment. However, given the biological diversity and donor-specific effects, more primary epithelial cells directly isolated from more human or animal tissues by enzymatic or mechanical methods need to be collected to further precisely assess the impact of LPS on the transcriptome of nasal epithelial cells in the future. Second, we only used LPS originated from Escherichia coli in the present study, however, there are also other gram-negative bacteria detected in nasal cavity of chronic rhinosinusitis patients27,28,29, thus, other LPS derived from other gram-negative bacteria including Fusobacterium species, Proteus vulgaris, Salmonella typhosa, Klebsiella pneumonia and Pseudomonas aeruginosa need to be used to further comprehensively evaluate the impact of LPS on the transcriptome and inflammatory responses of nasal epithelial cells in the future.
Conclusions
LPS intervention significantly alters the transcriptome of HNEpC. LPS may exacerbate inflammatory responses in HNEpC by activating chemokine-related signaling pathways.
Data availability
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found as below: https://www.ncbi.nlm.nih.gov/geo/, GSE241554.
References
Sijmons, D., Guy, A. J., Walduck, A. K. & Ramsland, P. A. Helicobacter pylori and the role of lipopolysaccharide variation in innate immune evasion. Front. Immunol. 13, 868225 (2022).
Wang, J. et al. SIRT6 protects against lipopolysaccharide-induced inflammation in human pulmonary lung microvascular endothelial cells. Inflammation 47, 323–332 (2023).
Liu, Y., Li, H., Ouyang, Y., Zhang, Y. & Pan, P. Exploration of the role of oxidative stress-related genes in LPS-induced acute lung injury via bioinformatics and experimental studies. Sci. Rep. 13, 21804 (2023).
Perez-Perez, D., Santos-Argumedo, L., Rodriguez-Alba, J. C. & Lopez-Herrera, G. Role of protein kinase A activation in the immune system with an emphasis on lipopolysaccharide-responsive and beige-like anchor protein in B cells. Int. J. Mol. Sci. 24, 3098 (2023).
Brindle, A., Bainbridge, C., Kumar, M. R., Todryk, S. & Padget, K. The Bisdioxopiperazine ICRF-193 attenuates LPS-induced IL-1beta secretion by macrophages. Inflammation 39, 1003 (2023).
Lin, H. et al. LPS-aggravated ferroptosis via disrupting circadian rhythm by Bmal1/AKT/p53 in sepsis-induced myocardial injury. Inflammation 46, 1133–1143 (2023).
Luo, C. et al. Increased CYR61 expression activates CCND1/c-Myc pathway to promote nasal epithelial cells proliferation in chronic rhinosinusitis with nasal polyps. Clin. Immunol. 247, 109235 (2023).
Yang, C., Shangguan, C., Cai, C., Xu, J. & Qian, X. LncRNA HCP5 participates in the tregs functions in allergic rhinitis and drives airway mucosal inflammatory response in the nasal epithelial cells. Inflammation 45, 1281–1297 (2022).
Choi, Y. S., Na, H. G., Bae, C. H., Song, S. Y. & Kim, Y. D. Ghrelin downregulates lipopolysaccharide/leptin-induced MUC5AC expression in human nasal epithelial cells. Clin. Exp. Otorhinolaryngol. 16, 49–58 (2023).
Pausder, A. et al. Exogenous and endogenous triggers differentially stimulate Pigr expression and antibacterial secretory immunity in the murine respiratory tract. Lung. 200, 119–128 (2022).
Lin, H., Li, Z., Lin, D., Zheng, C. & Zhang, W. Role of NLRP3 inflammasome in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Inflammation 39, 2045–2052 (2016).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587–D592 (2023).
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947–1951 (2019).
Varenyiova, Z. et al. Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia. Sci. Rep. 13, 14453 (2023).
Wee, J. H. et al. Effect of lipopolysaccharide and polyinosinic:polycytidylic acid in a murine model of nasal polyp. Sci. Rep. 11, 1021 (2021).
Li, Z. et al. Transcriptome analysis of porcine PBMCs reveals lipopolysaccharide-induced immunomodulatory responses and crosstalk of immune and glucocorticoid receptor signaling. Virulence 12, 1808–1824 (2021).
Hsieh, C. Y., Rajanbabu, V., Pan, C. Y. & Chen, J. Y. Transcriptome analysis reveals modulation of differentially expressed genes in LPS-treated mouse macrophages (RAW264.7 cells) by grouper (Epinephelus coioides) Epinecidin-1. Fish Shellfish Immunol. 139, 108880 (2023).
Zhu, Y. et al. M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps. Front. Immunol. 13, 1047930 (2022).
Li, R. R., Zeng, J. Q. & Ren, T. Expression of DEL-1 in alveolar epithelial cells prevents lipopolysaccharide-induced inflammation, oxidative stress, and eosinophil recruitment in acute lung injury. Int. Immunopharmacol. 110, 108961 (2022).
Miao, R. & Huang, J. MCC950 improves lipopolysaccharide-induced systemic inflammation in mice by relieving pyroptosis in blood neutrophils. Exp. Ther. Med. 26, 417 (2023).
Kim, T. H., Heo, S. Y., Han, J. S. & Jung, W. K. Anti-inflammatory effect of polydeoxyribonucleotides (PDRN) extracted from red alga (Porphyra sp.) (Ps-PDRN) in RAW 264.7 macrophages stimulated with Escherichia coli lipopolysaccharides: A comparative study with commercial PDRN. Cell Biochem. Funct. 41, 889–897 (2023).
Villain, E. et al. Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks. iScience. 26, 107422 (2023).
Adori, M., Khoenkhoen, S., Zhang, J., Dopico, X. C. & Karlsson Hedestam, G. B. Enhanced B cell receptor signaling partially compensates for impaired toll-like receptor 4 responses in LPS-stimulated IkappaBNS-deficient B cells. Cells 12, 1229 (2023).
Tiotiu, A. et al. Association of differential mast cell activation with granulocytic inflammation in severe asthma. Am. J. Respir. Crit. Care Med. 205, 397–411 (2022).
Kim, D., Assiri, A. M. & Kim, J. H. Recent trends in bacteriology of adult patients with chronic rhinosinusitis. J. Clin. Med. 8, 1889 (2019).
Leszczynska, J., Stryjewska-Makuch, G., Scierski, W. & Lisowska, G. Bacterial flora of the nose and paranasal sinuses among patients over 65 years old with chronic rhinosinusitis who underwent endoscopic sinus surgery. Clin. Interv. Aging 15, 207–215 (2020).
Jiang, R. S. & Liang, K. L. Comparison of bacteriology between eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps. Otolaryngol. Head Neck Surg. 168, 1545–1550 (2023).
Funding
This work was supported by grants from the National Natural Science Foundation of China (No.82271137, No. 82071014, No. 81870700 and No. 82000951), Clinical Science and Technology Innovation Project of Shanghai Shen-Kang Hospital Management Center (SHDC12020129), Science and Technology Innovation Action Plan of Science and Technology Commission of Shanghai Municipality (No. 19411950700), Shanghai Top-Priority Research Center Construction Project (2023ZZ02008) and the Key Laboratory Funding of Science and Technology Commission of Shanghai Municipality (No. 18DZ2260200).
Author information
Authors and Affiliations
Contributions
H.L. and W.Z. conceived the study, designed the experiments, analysed results, and wrote the main manuscript text. H.L., S.T. and Y.G. performed the experiments. H.L., S.T., Y.G, Y.Z. and C.L. performed bioinformatics analysis. H.L., S.T. and Z.L. performed the statistical analysis and prepared the figures. All authors reviewed and approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tan, S., Gu, Y., Zhu, Y. et al. Insights from bioinformatics analysis reveal that lipopolysaccharide induces activation of chemokine-related signaling pathways in human nasal epithelial cells. Sci Rep 14, 7672 (2024). https://doi.org/10.1038/s41598-024-58317-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-58317-y
- Springer Nature Limited